Stay updated on GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Sign up to get notified when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.

Latest updates to the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page
- Check2 days agoChange DetectedThe revision tag in the page footer was updated from v3.5.3 to v3.5.4, signaling a minor version update of the platform. This change does not modify the displayed study information or navigation.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s footer/site build has been updated from Revision v3.5.2 to v3.5.3, reflecting a website release rather than any change to the clinical trial information.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2. This appears to be a metadata update rather than a substantive change to the study content.SummaryDifference0.0%

- Check59 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check94 days agoChange DetectedSite revision updated to Revision: v3.4.2, replacing the previous Revision: v3.4.1 banner. The funding-status notice about government funding delays was removed, with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.